Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Androgen Receptor
    (2)
  • GABA Receptor
    (1)
  • P450
    (1)
  • Others
    (1)
Filter
Search Result
Results for "apalutamide" in TargetMol Product Catalog
  • Inhibitor Products
    7
    TargetMol | Activity
  • Isotope products
    4
    TargetMol | inventory
Apalutamide-COOH
T387251332391-04-4
Apalutamide-COOH is a metabolite derived from Apalutamide, which acts as a highly potent and competitive antagonist of the androgen receptor (AR). It effectively binds to the AR with an IC50 value of 16 nM.
  • $289
7-10 days
Size
QTY
TargetMol | Inhibitor Sale
Apalutamide
T2339956104-40-8
Apalutamide (ARN-509) is a small molecule and androgen receptor (AR) antagonist with potential antineoplastic activity.
  • $48
In Stock
Size
QTY
Apalutamide-d4
TMIH-00931638885-65-0
Apalutamide-d4 is a deuterated compound of Apalutamide.
  • $338
7-10 days
Size
QTY
Apalutamide-d7
TMIH-0094
Apalutamide-d7 is a deuterated compound of Apalutamide. Apalutamide has a CAS number of 956104-40-8. Apalutamide is a small molecule and androgen receptor (AR) antagonist with potential antineoplastic activity.
  • $685
7-10 days
Size
QTY
N-desmethyl Apalutamide-d4
TMIH-0372
N-desmethyl Apalutamide-d4 is a deuterated compound of N-desmethyl Apalutamide. N-desmethyl Apalutamide has a CAS number of 1332391-11-3. N-Desmethyl-Apalutamide is a less potent antagonist of the androgen receptor, is an active Apalutamide metabolite.
  • $438
7-10 days
Size
QTY
Apalutamide-13C-d3
TMIH-0092
Apalutamide-13C-d3 is the 13C and deuterated compound of Apalutamide. Apalutamide has a CAS number of 956104-40-8. Apalutamide is a small molecule and androgen receptor (AR) antagonist with potential antineoplastic activity.
  • $685
7-10 days
Size
QTY
N-Desmethyl-Apalutamide
T121461332391-11-3
N-Desmethyl-Apalutamide is a less potent antagonist of the androgen receptor, is an active Apalutamide metabolite.
  • $198
In Stock
Size
QTY